Brown Advisory’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Brown Advisory’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-34,536	Closed	-$112K	–	1048
2020 Q3	$112K	Buy	+34,536	New	+$116K	﹤0.01%	934
2019 Q2	–	Sell	-74,600	Closed	-$392K	–	1312
2019 Q1	$392K	Hold	74,600	–	–	﹤0.01%	1052
2018 Q4	$114K	Sell	74,600 -400	-0.5%	-$1.43K	﹤0.01%	1208
2018 Q3	$304K	Hold	75,000	–	–	﹤0.01%	1140
2018 Q2	$292K	Hold	75,000	–	–	﹤0.01%	1117
2018 Q1	$251K	Sell	75,000 -35,000	-32%	-$222K	﹤0.01%	1039
2017 Q4	$759K	Buy	+110,000	New	+$763K	﹤0.01%	758

Other funds holding PLXP

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

HWA

Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brown Advisory's PLXP Position: Q4 2020 in Review

Brown Advisory sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2020, closing a stake of 34,536 shares — an estimated $112K sold.

Brown Advisory first reported a position in PLXP in Q4 2017 and held it in 7 quarters. The position peaked at $759K in Q4 2017. 16 funds tracked by Wall St. Rank hold PLXP as of Q4 2020.

Brown Advisory reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Brown Advisory sold 34,536 PLx Pharma Inc. Common Stock shares in Q4 2020, an estimated $112K.
Brown Advisory first reported a position in PLx Pharma Inc. Common Stock in Q4 2017 and held it in 7 quarters.
Brown Advisory's PLx Pharma Inc. Common Stock position peaked at $759K in Q4 2017.
16 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2020.

Based on Brown Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.